Sumitomo Chemical India Ltd
Sumitomo Chemical India Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
The company targets growth at least in line with market growth as a base confidence point. Sumitomo Chemical India Limited expects sustainable growth in earnings and profits, with a focus on maintaining or improving EBITDA margins as stated by management.
From Sumitomo Chemical India Ltd's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- The company targets growth at least in line with market growth as a base confidence point.
- They aim to grow more than industry growth by launching new, innovative products and driving extensive farmer engagement and demand generation.
- The strategy has achieved nearly 14x growth over the past 15 years and is expected to continue delivering strong growth.
- Specialty molecules and new product launches like Meshi, Excalia Max, Lentigo, and Mera 71 have shown promising traction and volume ramp-up despite weather setbacks.
- New products contribute approximately 8-10% annually and the company expects both specialty and basic segments to grow.
- Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand.
2 more points from Sumitomo Chemical India Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Sumitomo Chemical India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Potential capex of INR 500-600 crores over next 5 years at Dahej for 6-7 molecules, with capacity utilization extending up to 10-12 years.
- Initial Dahej capex phase of INR 250-300 crores expected to be approved and implemented during current financial year; revenue generation projected from calendar year 2028 with 18-24 months implementation timeline.
- Tarapur site has undergone INR 55 crores capex with partial utilization for domestic products; additional INR 10 crores planned for futuristic products.
- Bhavnagar site capex completed; second phase INR 55 crores capex underway to double capacity by end of 2026.
- Cash reserves (~INR 2,100 crores) targeted for deployment primarily in Dahej capex and other business opportunities; no plans for special dividends currently.
2 more points from Sumitomo Chemical India Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sumitomo Chemical India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not provide explicit details on the current or expected orderbook or pending orders for Sumitomo Chemical India Limited.
- However, there is mention of strong demand outlook and ongoing customer engagements, particularly with initiatives like "Every Day Farmers Day" to deepen farmer connect and generate demand.
- The company is focused on scaling up recently launched products and expanding its domestic and export markets, indicating a positive pipeline of orders.
- Export demand is tied to regulatory approvals and seasonality but is expected to improve, especially in Africa and Latin America.
2 more points from Sumitomo Chemical India Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Sumitomo Chemical India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹671 Cr, net profit ₹111 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sumitomo Chemical India Ltd's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q4 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q2 FY22 earnings call →
Others in Fertilizers & Agrochemicals this season
- Bhagiradha Chemicals & Industries Ltd (Q2 FY26)
140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran
- Paradeep Phosphates Ltd (Q2 FY26)
3,600 crore. Key concall takeaways from Paradeep Phosphates Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
- Sharda Cropchem Ltd (Q2 FY26)
Regarding longer-term growth, the management is cautious and does not speculate, but acknowledges that reaching INR10,000 crores in 4 to 5 years could happen…
- Bayer CropScience Ltd (Q2 FY26)
. Key concall takeaways from Bayer CropScience Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Sumitomo Chemical India Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sumitomo Chemical India Ltd Q2 FY26 results?
The company targets growth at least in line with market growth as a base confidence point. Sumitomo Chemical India Limited expects sustainable growth in earnings and profits, with a focus on maintaining or improving EBITDA margins as stated by management.
What is Sumitomo Chemical India Ltd share price analysis?
Sumitomo Chemical India Ltd currently shows a neutral. The stock trades at a P/E of 46.7 with a market cap of ₹26,687 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sumitomo Chemical India Ltd planning capital expenditure?
Potential capex of INR 500-600 crores over next 5 years at Dahej for 6-7 molecules, with capacity utilization extending up to 10-12 years.
Keep Sumitomo Chemical India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.